Last Updated on January 8, 2024 by The Health Master
NPPA has fixed retail prices of three formulations under Drugs Prices Control Order (DPCO) – 2013 vide notification no. S. O. 4498(E) dt 11-12-2020, relating to 81st Authority meeting dated November 24, 2020.
To read download the notification no. S. O. 4498(E) dt 11-12-2020, click here
Name of the formulations are:
Ofloxacin + dexamethasone sodium phosphate eye/ear drops and ascorbic acid (Vitamin C) + zinc chewable tablet.
The manufacturer of this formulation i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified. The manufacturer may add goods and services tax only if they have paid actually or it is payable to the government on the retail price as prescribed by NPPA.
The retail price for a pack of these formulations shall be arrived at by the concerned manufacturer in accordance with the retail price specified as per provisions contained in paragraph 11 of the DPCO, 2013.
The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller (SDC) and dealers.
Also read | Indian Pharma Cos to benefit from increasing demand in US: Report
As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
The retail price fixed is applicable only to the individual manufacturer/marketer as specified i.e. who have applied for the same by submitting Form-I for price fixation/revision as stipulated under DPCO 2013.
Also read other NPPA news, click here
The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.
Follow and connect with us on Facebook, Linkedin
